Oppenheimer Asset Management Inc. Invests $981,000 in Maximus, Inc. $MMS

Oppenheimer Asset Management Inc. acquired a new stake in Maximus, Inc. (NYSE:MMSFree Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 18,241 shares of the health services provider’s stock, valued at approximately $981,000.

Several other institutional investors and hedge funds also recently made changes to their positions in MMS. Farther Finance Advisors LLC raised its position in Maximus by 69.0% in the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after purchasing an additional 116 shares during the period. Advisory Services Network LLC bought a new stake in Maximus in the third quarter worth $32,000. Canada Pension Plan Investment Board purchased a new stake in Maximus during the second quarter valued at about $35,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Maximus by 225.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock valued at $38,000 after buying an additional 304 shares during the last quarter. Finally, Danske Bank A S bought a new position in shares of Maximus during the third quarter valued at about $55,000. Institutional investors own 97.21% of the company’s stock.

Analyst Upgrades and Downgrades

MMS has been the topic of several analyst reports. Weiss Ratings downgraded Maximus from a “hold (c)” rating to a “hold (c-)” rating in a report on Wednesday, May 20th. Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a report on Saturday, August 8th. Finally, Zacks Research lowered Maximus from a “hold” rating to a “strong sell” rating in a research report on Tuesday, August 11th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Maximus presently has a consensus rating of “Reduce”.

Check Out Our Latest Stock Analysis on MMS

Maximus Price Performance

MMS stock opened at $55.24 on Monday. The firm’s 50-day moving average price is $58.05 and its two-hundred day moving average price is $65.73. Maximus, Inc. has a 12-month low of $52.73 and a 12-month high of $100.00. The stock has a market capitalization of $2.89 billion, a price-to-earnings ratio of 8.16 and a beta of 0.59. The company has a current ratio of 2.42, a quick ratio of 2.42 and a debt-to-equity ratio of 0.90.

Maximus (NYSE:MMSGet Free Report) last posted its earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.01. The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. Maximus’s revenue for the quarter was down 5.1% on a year-over-year basis. During the same period in the prior year, the business posted $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. As a group, equities analysts predict that Maximus, Inc. will post 8.01 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be given a dividend of $0.33 per share. The ex-dividend date of this dividend is Friday, August 14th. This represents a $1.32 dividend on an annualized basis and a yield of 2.4%. Maximus’s dividend payout ratio is presently 19.50%.

About Maximus

(Free Report)

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.

Further Reading

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.